Citadel Advisors - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$666,180
-64.9%
176,238
-37.8%
0.00%
Q2 2023$1,899,772
+245.0%
283,548
+235.3%
0.00%
Q1 2023$550,589
+34.8%
84,576
+76.6%
0.00%
Q4 2022$408,562
-29.4%
47,897
-56.3%
0.00%
Q3 2022$579,000
-64.1%
109,670
-71.2%
0.00%
Q2 2022$1,615,000
+135.8%
380,966
+95.2%
0.00%
Q1 2022$685,000
+10.0%
195,156
+108.6%
0.00%
Q4 2021$623,000
-16.2%
93,565
+25.6%
0.00%
Q3 2021$743,000
-30.6%
74,492
+115.0%
0.00%
Q2 2021$1,070,000
-83.3%
34,648
-74.9%
0.00%
-100.0%
Q4 2020$6,401,000138,1380.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders